GR1002276B - Novel treatment. - Google Patents

Novel treatment.

Info

Publication number
GR1002276B
GR1002276B GR920100430A GR920100430A GR1002276B GR 1002276 B GR1002276 B GR 1002276B GR 920100430 A GR920100430 A GR 920100430A GR 920100430 A GR920100430 A GR 920100430A GR 1002276 B GR1002276 B GR 1002276B
Authority
GR
Greece
Prior art keywords
alkyl
hydrogen
alkylcarbonyl
nitro
alkoxy
Prior art date
Application number
GR920100430A
Other languages
Greek (el)
Other versions
GR920100430A (en
Inventor
Neil Upton
Morris John Evans
Mervyn Thompson
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of GR920100430A publication Critical patent/GR920100430A/en
Publication of GR1002276B publication Critical patent/GR1002276B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method of treatment and/or prophylaxis of anxiety and/or mani, and/or depression and/or the effects associated with withdrawal from substances of abuse, and/or disorders treatable and/or preventable with anticonvulsive agents, comprising administering to the sufferer in need therof an effective or prophylactic amount of a compound of formula (I) or pharmaceutically acceptable salt thereof : C H E M I C A L F O R M U L A wherein Y is N and R2 is hydrogen, or Y is C-R1 where : either one of R1 and r2 is hydrogen and the other is selected from the class of hydrogen, C3-8 cycloalkyl, C1-6 alkyl optionally interrupted by oxygen or substituted aminicarbonyl, c1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 alkylcarbonyloxy, C1-6 alkoxy, nitro, cyani, halo, trifluoromethyl, CF3S,or a group CF3-A-, where A is -CF2-, - CO-, -CH2- or CH(OH),trifluoromethoxy, C1-6 alkylsulphinyl, C1-6 alkoxysulphinyl, C1-6 alkoxysulphonyl, aryl, heteroaryl, arylcarbonyl,heteroarylcarbonyl, arylsulphinyl, heteroarylsulphinyl, arylsulphonyl, heteroarylsulphonyl in which any aromatic moiety is optionally substituted, C16- alkylcarbonylamino, C1-6 alkoxycarbonylamino, c1-6 alkyl- thiocarbonyl, C1-6 alkoxy-thiocarbonyl, C1-6 alkyl- thiocarbonyloxy, 1-mercapto C2-7 alkyl, formyl, or aminosulphinyl, aminosulphonyl or aminocaronyl, any amino moiety being optionally substituted by one or two C1-6 alkyl groups, or C1-6 alkylsulphinylamino, C1-6 alkylsulphonylamino, C1-6 alkoxysulphinylamino or C1-6 alkoxysulphonylamino, or ethylenyl terminall substituted by C1-6 alkylcarbonyl, nitro or cyano, or -C(C1-6 alkyl)NOH or - C(C1-6 alkyl)NNH2, or one of R1 and R2 is nitro, cyano or C1-3 alkylcarbonyl and the other is methoxy or amino optionally substituted by one or two c1-6 alkyl or by C2-7 alkanoyl; one of R3 and r4 is hydrogen or C1-4 alkyl and the other is C1-4 alkyl or R3 and R4 together are C2-5 polymethylene; R5is C1-6 alkylcarbonyloxy, benzoyloxy, ONO2, benzyloxy,phenyloxy or C1-6 alkoxy and R6 and R9 are hydrogen or R5 is hydroxy and R6 is hydrogen or C1-2 alkyl and R9 is hydrogen ; R7 is fluorophenyl ; R8 is hydrogen or C1-6 alkyl; the r8-N-CO-R7 group being trans to the R5 group; and X is oxygen or NR10 where r10 is hydrogen or C1-6 alkyl.
GR920100430A 1992-10-08 1992-10-08 Novel treatment. GR1002276B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR92100430 1992-10-08

Publications (2)

Publication Number Publication Date
GR920100430A GR920100430A (en) 1994-06-30
GR1002276B true GR1002276B (en) 1996-05-02

Family

ID=10941199

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920100430A GR1002276B (en) 1992-10-08 1992-10-08 Novel treatment.

Country Status (1)

Country Link
GR (1) GR1002276B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2064514B (en) * 1979-10-29 1984-01-18 Maruko Pharmaceutical Co Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
DE3479726D1 (en) * 1983-05-18 1989-10-19 Beecham Group Plc BENZOPYRAN DERIVATIVES.
DE3682331D1 (en) * 1985-06-08 1991-12-12 Beecham Group Plc PYRANO (3,2-C) PYRIDE DERIVATIVES, METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
PT84806B (en) * 1986-05-03 1989-12-29 Beecham Group Plc PROCESS FOR THE PREPARATION OF BENZOPYRANES
FR2639349B1 (en) * 1988-11-23 1991-02-22 Sanofi Sa NOVEL CHROMANE DERIVATIVES ACTIVE IN THE CENTRAL NERVOUS SYSTEM, THEIR PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Also Published As

Publication number Publication date
GR920100430A (en) 1994-06-30

Similar Documents

Publication Publication Date Title
ES8601180A1 (en) Benzopyran derivatives.
ES8407036A1 (en) Novel chromenes and chromans.
PT80689A (en) Process for the preparation of novel chroman and chromene compounds having pharmacological activity pharmaceutical compositions containing same and theier use in the treatment of mammals
ES8406464A1 (en) Pharmaceutically active aminobenzopyrans.
ES2143541T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING BICYCLE-TYPE COMPOUNDS.
PL346427A1 (en) Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
TW239140B (en)
PT1109809E (en) PYROLOCHINOLINS FOR TREATMENT OF OBESITY
NZ504991A (en) Pharmaceutical compositions containing micronized benzopyran or pyridopyran derivatives, and their use as medicaments
SG48284A1 (en) Benzo-and pyridopyran deriatives having anxiolytic and anti-convulsant activity
GR1002276B (en) Novel treatment.
GB9819032D0 (en) Chemical compounds IV
AU4892190A (en) Process for the preparation of pure (3S,4R)-4-pyrrolidon- 1-yl (or 4-piperidon-1-yl)-3,4-dihydrobenzo pyran-3-ol derivatives
CA2151507A1 (en) Pharmaceutical composition containing bicyclic type compounds
SI9200378B (en) Benzopyran derivates and heterocyclic analogs thereof as pharmacologically active agents

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees